DOXYCYCLINE HYCLATE
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC with contract SPE2DP25F7394, issued on July 30, 2026, under the parent contract SPE2DX15D9383, to supply DOXYCYCLINE HYCLATE identified by NSN 6505016421190. This delivery order is part of a federal procurement effort to ensure pharmaceutical readiness for the Department of Defense, with no set-aside designation specified and the award proceeding under a full and open competition. The total contract price is detailed in the official award documentation, and the place of performance and point of contact information have not been provided, though the contract originates from a U.S. federal agency. The award is accessible via the DIBBS portal, reflecting standard DLA procurement procedures for critical medical supplies.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
